Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Norman

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|October 24, 2007
Three-dimensional quantitative structure-activity relationships and activity predictions of human TRPV1 channel antagonists: comparative molecular field analysis and comparative molecular similarity index analysis of cinnamidesVellarkad N Viswanadhan, Yaxiong Sun, Mark H Norman
Bioorganic & Medicinal Chemistry Letters|February 27, 2008
4-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility propertiesElizabeth M Doherty, Daniel Retz, Narender R Gavva, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Structure-activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonistsVijay K Gore, Vu V Ma, Ruoyuan Yin, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2007
Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonistsVijay K Gore, Vu V Ma, Rami Tamir, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide coreNing Xi, Clarence Hale, Michael G Kelly, et al.
Molecular Pharmacology|September 2, 2005
Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1Narender R Gavva, Rami Tamir, Lana Klionsky, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2009
Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitorsMatthew R Kaller, Wenge Zhong, Charles Henley, et al.
Pharmacological Reviews|September 15, 2009
The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is notAndrej A Romanovsky, Maria C Almeida, Andras Garami, et al.
Journal of Medicinal Chemistry|February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivativesMark H Norman, Longbin Liu, Matthew Lee, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Substituted aryl pyrimidines as potent and soluble TRPV1 antagonistsMarkian M Stec, Yunxin Bo, Partha P Chakrabarti, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|October 24, 2007
Three-dimensional quantitative structure-activity relationships and activity predictions of human TRPV1 channel antagonists: comparative molecular field analysis and comparative molecular similarity index analysis of cinnamidesVellarkad N Viswanadhan, Yaxiong Sun, Mark H Norman
Bioorganic & Medicinal Chemistry Letters|February 27, 2008
4-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility propertiesElizabeth M Doherty, Daniel Retz, Narender R Gavva, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Structure-activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonistsVijay K Gore, Vu V Ma, Ruoyuan Yin, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2007
Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonistsVijay K Gore, Vu V Ma, Rami Tamir, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide coreNing Xi, Clarence Hale, Michael G Kelly, et al.
Molecular Pharmacology|September 2, 2005
Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1Narender R Gavva, Rami Tamir, Lana Klionsky, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2009
Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitorsMatthew R Kaller, Wenge Zhong, Charles Henley, et al.
Pharmacological Reviews|September 15, 2009
The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is notAndrej A Romanovsky, Maria C Almeida, Andras Garami, et al.
Journal of Medicinal Chemistry|February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivativesMark H Norman, Longbin Liu, Matthew Lee, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Substituted aryl pyrimidines as potent and soluble TRPV1 antagonistsMarkian M Stec, Yunxin Bo, Partha P Chakrabarti, et al.
Pageof 6